Point72 Asset Management L.P. Sells 255,344 Shares of Progyny, Inc. (NASDAQ:PGNY)

Point72 Asset Management L.P. lessened its stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 32.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 534,074 shares of the company's stock after selling 255,344 shares during the quarter. Point72 Asset Management L.P. owned approximately 0.63% of Progyny worth $9,213,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Progyny by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 8,692,132 shares of the company's stock valued at $149,939,000 after acquiring an additional 48,271 shares during the period. Pacer Advisors Inc. raised its stake in Progyny by 47.5% in the 4th quarter. Pacer Advisors Inc. now owns 3,676,200 shares of the company's stock valued at $63,414,000 after acquiring an additional 1,183,558 shares during the period. River Road Asset Management LLC bought a new stake in Progyny in the 4th quarter valued at $25,529,000. Fort Washington Investment Advisors Inc. OH raised its stake in Progyny by 90.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company's stock valued at $25,319,000 after acquiring an additional 695,740 shares during the period. Finally, Barclays PLC raised its stake in Progyny by 95.7% in the 4th quarter. Barclays PLC now owns 1,382,205 shares of the company's stock valued at $23,843,000 after acquiring an additional 676,048 shares during the period. Institutional investors and hedge funds own 94.93% of the company's stock.

Progyny Trading Down 1.8%

PGNY stock traded down $0.37 during trading hours on Friday, hitting $20.52. 822,500 shares of the stock were exchanged, compared to its average volume of 1,712,711. The firm has a market capitalization of $1.76 billion, a P/E ratio of 35.38, a P/E/G ratio of 2.39 and a beta of 1.37. The company has a 50-day simple moving average of $22.15 and a two-hundred day simple moving average of $19.96. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $30.42.

Progyny (NASDAQ:PGNY - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.28). The company had revenue of $324.04 million for the quarter, compared to analyst estimates of $307.86 million. Progyny had a return on equity of 11.36% and a net margin of 5.03%. The business's revenue for the quarter was up 16.5% compared to the same quarter last year. During the same period last year, the company posted $0.17 earnings per share. On average, equities research analysts predict that Progyny, Inc. will post 0.6 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on PGNY. JPMorgan Chase & Co. increased their price target on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research note on Tuesday, January 28th. Bank of America increased their price target on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price target on the stock in a research note on Monday, March 31st. Finally, Canaccord Genuity Group dropped their price target on Progyny from $23.00 to $21.00 and set a "hold" rating on the stock in a research note on Monday, May 12th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $23.45.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.